Apyx Medical Corporation (APYX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,936
Total Return
-60.64%
CAGR
-17.02%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +2.24% |
| Median | -2.22% |
| Best | +121.12% |
| Worst | -67.14% |
| % of Windows Positive | 46.3% |
1-Year (252 Trading Days)
| Average | +5.34% |
| Median | -32.45% |
| Best | +354.13% |
| Worst | -91.95% |
| % of Windows Positive | 34.1% |
3-Year (756 Trading Days)
| Average | -44.14% |
| Median | -72.96% |
| Best | +186.43% |
| Worst | -92.45% |
| % of Windows Positive | 24.0% |
Risk Metrics
| Maximum Drawdown | -94.99% |
| Average Drawdown | -71.66% |
| Drawdown Duration | 1135 Trading Days (Unrecovered) |
| Sortino Ratio | 0.50 |
| Calmar Ratio | -0.18 |
| CVaR (5%) | -12.77% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +8.29% (+20.78% ann.) | +$828.59 | $0.00 | $0.00 | $0.00 |
| 2025 | +121.52% | +$12151.89 | $0.00 | $0.00 | $0.00 |
| 2024 | -39.69% | $3969.47 | $0.00 | $0.00 | $0.00 |
| 2023 | +11.97% | +$1196.59 | $0.00 | $0.00 | $0.00 |
| 2022 | -81.75% | $8174.73 | $0.00 | $0.00 | $0.00 |
| 2021 | +78.06% | +$7805.56 | $0.00 | $0.00 | $0.00 |
| 2020 | -14.89% | $1489.36 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +30.76% (+30.97% ann.) | +$3075.73 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | January 2, 2019 – February 19, 2020 | +17.47% | +15.30% | +$1746.52 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -57.26% | -99.99% | $5725.59 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +72.83% | +141.18% | +$7283.24 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +110.92% | +103.00% | +$11091.77 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -67.24% | -69.42% | $6723.75 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -37.93% | -22.69% | $3793.12 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +260.95% | +112.24% | +$26095.37 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.